Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-20

FDA Approved: VALSARTAN — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for valsartan submitted by Lupin Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALSARTAN (Valsartan)

Snippet

SUPPL AP for VALSARTAN (VALSARTAN)